Stock Analysis

Atturra Full Year 2024 Earnings: Beats Expectations

Published
ASX:ATA

Atturra (ASX:ATA) Full Year 2024 Results

Key Financial Results

  • Revenue: AU$243.4m (up 37% from FY 2023).
  • Net income: AU$9.78m (down 4.5% from FY 2023).
  • Profit margin: 4.0% (down from 5.7% in FY 2023). The decrease in margin was driven by higher expenses.
  • EPS: AU$0.036 (down from AU$0.047 in FY 2023).
ASX:ATA Earnings and Revenue Growth August 27th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Atturra Revenues and Earnings Beat Expectations

Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) also surpassed analyst estimates by 12%.

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 14% growth forecast for the IT industry in Australia.

Performance of the Australian IT industry.

The company's shares are up 12% from a week ago.

Risk Analysis

Don't forget that there may still be risks. For instance, we've identified 1 warning sign for Atturra that you should be aware of.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.